DLD Asset Management, LP
Q3 2025 13F-HR/A Holdings
Net value change ($000)
+174,094
(14.4%)
New positions
88
Sold out positions
53
Turnover %
88.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ELME | 7,290 | NEW |
| U | 6,078 | NEW |
| MCGA | 5,348 | NEW |
| GTLS | 5,231 | NEW |
| VRNS | 5,079 | NEW |
| LBRDA | 4,636 | NEW |
| EA | 4,006 | NEW |
| CYBR | 3,442 | NEW |
| AL | 3,335 | NEW |
| FTW | 3,064 | 143.4% |
Top Reduces (Value $000, Stocks/ETFs)
| iTeos Therapeutics, Inc. | -5,749 | -100.0% |
| KDK | -5,447 | -100.0% |
| IMSR | -5,204 | -100.0% |
| EXAS | -3,821 | -100.0% |
| Cohen Circle Acquisition Corp. I | -3,789 | -100.0% |
| GWRE | -3,688 | -51.0% |
| CRAQ | -3,078 | -100.0% |
| PPTA | -2,914 | -100.0% |
| Third Harmonic Bio, Inc. | -2,736 | -100.0% |
| WENN | -2,643 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
607,538
(43.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|